𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The degradation profile of novel, bioresorbable PCL–TCP scaffolds: An in vitro and in vivo study

✍ Scribed by A. Yeo; B. Rai; E. Sju; J.J. Cheong; S.H. Teoh

Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
627 KB
Volume
84A
Category
Article
ISSN
1549-3296

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Degradation studies of scaffolds are important in bone tissue engineering. Previously, novel poly(ε‐caprolactone)–20% tricalcium phosphate (PCL–TCP) based scaffolds were developed and proven useful for bone regeneration. In this study in vitro degradation analyses were carried out with the PCL–TCP scaffolds immersed in standard culture medium for 24 weeks. In vivo degradation was performed with the scaffolds implanted in the abdomen of rats for the same period of time. Results demonstrated greater degradation of PCL–TCP scaffolds in vivo than in vitro. At 24 weeks, the increase of average porosity of the scaffolds in vivo was 29.2% compared to 2.65% in vitro. Gel permeation chromatography (GPC) analysis revealed a decrease of 29% and 20% respectively in the M~n~ and M~w~ values after 24 weeks in vitro. However, a significant decrease in M~n~ and M~w~ values (79.6% and 88.7% respectively) were recorded in vivo. The mechanical properties however, were relatively similar and closely match those of cancellous bone even at 24 weeks. The results showed that the scaffold can be used for dentoalveolar reconstruction and PCL–TCP scaffolds have shown to possess the potential to degrade within the desired time period of 5–6 months and favorable mechanical properties. © 2007 Wiley Periodicals, Inc. J Biomed Mater Res, 2008

📜 SIMILAR VOLUMES

Surface modification of PCL-TCP scaffold
Surface modification of PCL-TCP scaffolds in rabbit calvaria defects: Evaluation of scaffold degradation profile, biomechanical properties and bone healing patterns
✍ Alvin Yeo; Wah Jie Wong; Swee-Hin Teoh 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 545 KB

## Abstract Traditionally, polycaprolactone (PCL) based scaffolds tend to degrade at a slow rate. Pretreatment of polycaprolactone‐20% tricalcium phosphate (PCL‐TCP) scaffolds under alkaline conditions can be utilized to increase the degradation rate and improve mechanical properties. Three groups

Surface modification of PCL-TCP scaffold
Surface modification of PCL-TCP scaffolds improve interfacial mechanical interlock and enhance early bone formation: An in vitro and in vivo characterization
✍ A. Yeo; W. J. Wong; H. H. Khoo; S. H. Teoh 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 499 KB

## Abstract Pretreatment of polycaprolactone‐20% tricalcium phosphate (PCL‐TCP) scaffolds under alkaline conditions can be utilized to alter surface characteristics for enhanced early bone formation. PCL‐TCP scaffolds were treated with sodium hydroxide (NaOH) at various time intervals (group A: unt

A novel porous collagen scaffold around
A novel porous collagen scaffold around an implantable biosensor for improving biocompatibility. I. In vitro/in vivo stability of the scaffold and in vitro sensitivity of the glucose sensor with scaffold
✍ Young Min Ju; Bazhang Yu; Thomas J. Koob; Yvonne Moussy; Francis Moussy 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 486 KB 👁 1 views

## Abstract A new 3D porous and biostable collagen scaffold has been developed to improve the biocompatibility of implantable glucose sensors by minimizing tissue reactions while stimulating angiogenesis around the sensors. The novel collagen scaffold was crosslinked using nordihydroguaiaretic acid

Efficacy of transfection rates on head a
Efficacy of transfection rates on head and neck squamous cell cancer by a novel adenovirus: An in vivo and in vitro study
✍ Elise S. Lalonde; Gregory Beyer; Paul L. Friedlander; Jay K. Kolls 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 145 KB

## Abstract ## Introduction Internalization of wild‐type adenovirus is dependent on binding to a coxsackie‐adenovirus receptor (CAR). Unfortunately, many tumors lack these receptors. We hypothesized that a novel RGD adenovirus, which binds by way of cellular integrins, would improve the transfecti